Follow The Filings

KREF

Earnings company data as of 8:00 PM ET 10/22

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 28 Oct EPS 0.02 — —
Rev — — —

Insider trades

Open-market buys and sales by KREF's executives, directors and 10% owners in the last 12 months, from their Form 4s

All KREF insider trades
  • $1.2M bought by 4 insiders
  • $2.1M sold by 1 insider outside a trading plan
  • None no planned (10b5-1) sales
  1. Matthew A Salem CEO
    Buy
    $362K 60,000 shares at $6.04 +9.3% to stake
    Traded Apr 24 Filed Apr 27
  2. W Patrick Mattson COO
    Buy
    $241K 40,000 shares at $6.03 +8.7% to stake
    Traded Apr 24 Filed Apr 27
  3. Ralph F Rosenberg Director
    Sale
    $2.1M 250,578 shares at $8.25
    Traded Dec 3, 2025 Filed Dec 3, 2025
  4. Terrance R Ahern Director
    Buy
    $185K 23,700 shares at $7.81 +61% to stake
    Traded Nov 6, 2025 Filed Nov 10, 2025
  5. Christen E.j. Lee Director
    Buy
    $78K 10,000 shares at $7.80 +4.6% to stake
    Traded Nov 7, 2025 Filed Nov 10, 2025
  6. W Patrick Mattson COO
    Buy
    $103K 13,000 shares at $7.91 +3.5% to stake
    Traded Nov 6, 2025 Filed Nov 10, 2025
  7. Matthew A Salem CEO
    Buy
    $251K 32,000 shares at $7.84 +6% to stake
    Traded Nov 6, 2025 Filed Nov 10, 2025

Also filed in the last 12 months, not counted as buying or selling: 9 stock grants, 2 share withholdings for taxes, and 1 other transaction.

SEC filings

Recent issuer filings from EDGAR, 18 shown.

Filed Form Detail Links
SCHEDULE 13G/A —
SCHEDULE 13G —
8-K 2.02,9.01
10-Q
SCHEDULE 13G —
8-K 2.02,9.01
10-Q
8-K 5.07
SCHEDULE 13G/A —
SCHEDULE 13G/A —
DEF 14A
DEFA14A
8-K 2.02,9.01
10-K
8-K 5.02
SCHEDULE 13G/A —
8-K 2.02,9.01
10-Q

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.